A carregar...
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) can reduce oedema, improve vision and prevent further visual loss. These drugs have replaced laser photocoagulation as the stand...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517135/ https://ncbi.nlm.nih.gov/pubmed/30325017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007419.pub6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|